Expertise

Ora’s success is built on a simple, fundamental principle: delivering ophthalmic expertise at every operational level and every stage of the development process. Across therapeutic areas and throughout all phases of development, you’ll have direct access to the brightest minds in ophthalmology with every study.

Therapeutic Areas of Specialty

Cornea & Ocular Surface

Leveraging therapeutic area experience, expansive site relationships, and proprietary technologies to deliver high-quality Cornea & Ocular Surface clinical trials.

Learn More

Retina & Macular Diseases

Implementing over three decades of experiences, combined with proven methods and models that deliver the highest quality data for Retina & Macular Disease studies.

Learn More

Glaucoma & Optic Neuropathies

Delivering successful Glaucoma & Optic Neuropathies clinical trials on time and on budget by utilizing a strategic site network, meticulous planning, and operational optimization.

Learn More

Inflammatory & AutoImmune

Our operational approach has evolved over the last 30 years to blend expert regulatory strategy, deep site relationships, and tailored recruitment plans to drive successful Inflammatory & Autoimmune clinical research.

Learn More

Cataracts & Refractive

Leading Cataracts & Refractive clinical research development through precision trial design, optimized enrollment, and a continuous learning loop from decades of experience.

Learn More

FREQUENTLY ASKED QUESTIONS

Have any questions? We’ve got answers.

What does Ora specialize in? Is Ora only ophthalmology?

At Ora, we take pride in our specialization in ophthalmology, and view our focus as a strength, not a limitation. Over our history, we’ve created a record of unsurpassed operational excellence, and committed ourselves to conducting the most rigorous science in our field.

The expertise and leadership we’ve developed extends to every subspecialty in ophthalmology, comfortably covering both pharma and device. Having directly assisted in over 85 product approvals, no one is better positioned to guide patients and partners through ophthalmic clinical research than we are.
Why choose Ora for your development programs?

Ora’s entire history and identity are centered exclusively around ophthalmology. No other company has the subject matter authority or the record of success that we have accrued, nor do they have the dedicated talent and resources that we can provide to every single program we work on. So long as you’re in ophthalmology, your specialty is ours, too.

Ora has the flexibility to provide whatever kind of support you need in order to succeed. Our in-house experts tailor their guidance to fit the exact requirements of your program, from regulatory strategy and CMC management to nonclinical program design, clinical protocols, and endpoint decisions. No matter where you are on the pathway of development, our team can help.
What does Ora provide in terms of Senior Leadership Experience?

Our department heads each have over 15 years of experience bringing new ophthalmic therapies and devices to market, and directly consult on every clinical study that we partner on.

Ora’s Chief Medical Officer is a practicing ophthalmologist and internationally recognized glaucoma specialist, with extensive clinical research experience. He maintains a part-time appointment at Columbia University, staying at the forefront of the field and always remaining close to the patients clinical research is meant to serve.

Our R&D team has developed novel endpoints that are sensitive enough to both identify the quality-of-life benefits investigational therapies bring to patients and precisely measure the degree of improvement.